MiraLAX
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-489 -
Package NDC
76420-489-10 -
Package NDC
76420-489-20 -
Package NDC
76420-489-24 -
Package NDC
76420-489-77 -
Package NDC
76420-489-85 -
Application number
NDA022015 -
SPL ID
411a7a72-348c-4e5b-e063-6294a90a6c7e -
SPL set ID
e652042f-3707-4bf6-831d-d806638b7d85 -
UNII
G2M7P15E5P -
RxCUI
876193 -
RxCUI
876195
What the source publishes
- Labeler
- ASCLEMED USA INC.
- Active ingredients
- Polyethylene Glycol 3350
- Form
- POWDER, FOR SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
Complete source data
{
"name": "MiraLAX",
"splId": "411a7a72-348c-4e5b-e063-6294a90a6c7e",
"labels": [
{
"setId": "e652042f-3707-4bf6-831d-d806638b7d85",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e652042f-3707-4bf6-831d-d806638b7d85",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e652042f-3707-4bf6-831d-d806638b7d85"
}
],
"routes": [
"ORAL"
],
"labeler": "ASCLEMED USA INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 PACKET in 1 CARTON (76420-489-10) / 17 g in 1 PACKET",
"package_ndc": "76420-489-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20251014"
},
{
"sample": false,
"description": "20 POUCH in 1 CARTON (76420-489-20) / 17 g in 1 POUCH",
"package_ndc": "76420-489-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20251014"
},
{
"sample": false,
"description": "24 PACKET in 1 CARTON (76420-489-24) / 17 g in 1 PACKET",
"package_ndc": "76420-489-24",
"identifierStatus": "well-formed",
"marketing_start_date": "20251014"
},
{
"sample": false,
"description": "765 g in 1 BOTTLE, PLASTIC (76420-489-77)",
"package_ndc": "76420-489-77",
"identifierStatus": "well-formed",
"marketing_start_date": "20251014"
},
{
"sample": false,
"description": "850 g in 1 BOTTLE, PLASTIC (76420-489-85)",
"package_ndc": "76420-489-85",
"identifierStatus": "well-formed",
"marketing_start_date": "20251014"
}
],
"productId": "76420-489_411a7a72-348c-4e5b-e063-6294a90a6c7e",
"useDomain": "unknown",
"dosageForm": "POWDER, FOR SOLUTION",
"productNdc": "76420-489",
"deaSchedule": null,
"genericName": "Polyethylene Glycol 3350",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "POLYETHYLENE GLYCOL 3350",
"strength": "17 g/17g"
}
],
"applicationNumber": "NDA022015",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20070201",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"nui": [
"N0000010288",
"N0000175811",
"N0000009871"
],
"unii": [
"G2M7P15E5P"
],
"rxcui": [
"876193",
"876195"
],
"spl_set_id": [
"e652042f-3707-4bf6-831d-d806638b7d85"
],
"pharm_class_pe": [
"Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"
],
"pharm_class_epc": [
"Osmotic Laxative [EPC]"
],
"pharm_class_moa": [
"Osmotic Activity [MoA]"
],
"manufacturer_name": [
"ASCLEMED USA INC."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-489_411a7a72-348c-4e5b-e063-6294a90a6c7e"